DSPE PEG Amine, DSPE-PEG-NH2 - MW 2000 Da, high purity , CAS No.474922-26-4

  • MW 2000 Da
Item Number
D163596
Grouped product items
SKUSizeAvailabilityPrice Qty
D163596-20mg
20mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$23.90
D163596-100mg
100mg
3
$59.90
D163596-500mg
500mg
7
$209.90

Basic Description

SynonymsDSPE-PEG-NH2 | DSPE-PEG2000-NH2 | PD070000 | DSPE-PEG-Amine | 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] Ammonium Salt | α-[(9R)-6-Hydroxy-6-oxido-1,12-dioxo-9-[(1-oxooctadecyl)oxy]-5,7,11-trioxa-2-aza-6-phosphanon
Specifications & PurityMW 2000 Da
Biochemical and Physiological MechanismsDSPE-PEG(2000) micelles facilitate solubilization and delivery of hydrophobic drugs. It is used to coat magnetic iron oxide nanoparticles
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
Product Description

DSPE PEG Amine (DSPE-PEG-NH2) is one of  reactive phospholipid PEG reagents that have a reactive primary amine group on one PEG terminus. DSPE (1,2-Distearoyl-sn-Glycero-3-Phosphoethanolamine) is a saturated 18C phospholipid commonly used in liposome synthesis.  Polyethylene glycol (PEG) conjugated DSPE has both hydrophilicity and hydrophobility property that is useful for drug delivery, gene transfection and biomolecule modification. Pegylation of phospholipids significantly improves the blood circulation time and stability for encapsulated drugs. Amine functionalized DSPE PEG allows further modification of PEG lipid via its reactive amino group.

Application:

DSPE-PEG-NH2 is a linear heterobifunctional PEGylation reagent with a DSPE phospholipid and an amine. DSPE-PEG-NH2 is used to modify liposome surface with biomolecules containing amine reactive groups (NHS, thiolate). It is a useful self-assembling reagent to prepare grafted or PEGylated liposome or micelle while also providing an amine group for bioconjugation. It is often used in targeted drug delivery with the lipid bilayer to improve drug solubility, the PEG to provide stealth property, extend circulation half-life and reduce non-specific protein binding or cell adhesion, and the amine group to bioconjugate targeting molecules including antibody, aptamer, protein, and peptide.

AI Insight

Names and Identifiers

Pubchem Sid504773717
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/504773717
IUPAC Name [3-[2-[2-(2-aminoethoxy)ethoxycarbonylamino]ethoxy-hydroxyphosphoryl]oxy-2-octadecanoyloxypropyl] octadecanoate;azane
INCHI InChI=1S/C46H91N2O11P.H3N/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-44(49)56-41-43(42-58-60(52,53)57-38-36-48-46(51)55-40-39-54-37-35-47)59-45(50)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h43H,3-42,47H2,1-2H3,(H,48,51)(H,52,53);1H3
InChi Key AXHRCGLQEUQOIS-UHFFFAOYSA-N
Canonical SMILES CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)OCCOCCN)OC(=O)CCCCCCCCCCCCCCCCC.N
Isomeric SMILES CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)OCCOCCN)OC(=O)CCCCCCCCCCCCCCCCC.N
PubChem CID 156592378

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

17 results found

Lot NumberCertificate TypeDateItem
G2303320Certificate of AnalysisApr 09, 2025 D163596
G2303380Certificate of AnalysisApr 09, 2025 D163596
H2429310Certificate of AnalysisJul 08, 2024 D163596
H2429309Certificate of AnalysisJul 08, 2024 D163596
H2429135Certificate of AnalysisJul 08, 2024 D163596
D2424259Certificate of AnalysisMar 09, 2024 D163596
A2403181Certificate of AnalysisDec 08, 2023 D163596
A2403180Certificate of AnalysisDec 08, 2023 D163596
I2314284Certificate of AnalysisFeb 27, 2023 D163596
I2314283Certificate of AnalysisFeb 27, 2023 D163596
G2303386Certificate of AnalysisFeb 13, 2023 D163596
G2303406Certificate of AnalysisFeb 13, 2023 D163596
G2303311Certificate of AnalysisFeb 03, 2023 D163596
K2209505Certificate of AnalysisAug 10, 2022 D163596
K2209506Certificate of AnalysisAug 10, 2022 D163596
B2225328Certificate of AnalysisJan 21, 2022 D163596
B2225321Certificate of AnalysisJan 21, 2022 D163596

Show more⌵

Related Documents

Reviews

Customer Reviews

Citations of This Product

1. Yan-ming Xia, Li-xin Hu, Yun-han Xia, Shi-xuan Li, Bo Shi, Chao Qin, Xiao-peng Han, Su-xin Li, Li-fang Yin.  (2024)  Rational surface modification of zirconium-based metal–organic framework nanomaterials for the adsorption and recovery of coloured drugs and proteins from aqueous solutions.  COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS,  681  (11): (132845).  [PMID:10660610] [10.1016/j.colsurfa.2023.132845]
2. Minghua Zhou, Beibei Tian, Yingcui Bu, Zhichao Wu, Jianhua Yu, Sen Wang, Xianshun Sun, Xiaojiao Zhu, Hongping Zhou.  (2023)  Enhanced pH-Responsive Chemo/Chemodynamic Synergistic Cancer Therapy Based on In Situ Cu2+ Di-Chelation.  ACS Applied Bio Materials,      [PMID:37428493] [10.1021/acsabm.3c00323]
3. Huaming He, Fang Zhao, Wukun Zhong, Yuling Yang, Yuhong Lin, Yihang Ding, Jiajia Yang, Chunhua Lu, Xiankun Tu.  (2022)  GSH-responsive sequential mitochondria-targeting nanoagents for photothermal-enhanced chemodynamic therapy.  MATERIALS & DESIGN,  219  (110722).  [PMID:] [10.1016/j.matdes.2022.110722]
4. Xiangqi Liu, Wei Feng, Huijing Xiang, Baihui Liu, Mujie Ye, Meng Wei, Rui Dong, Yu Chen, Kuiran Dong.  (2021)  Multifunctional cascade nanocatalysts for NIR-II-synergized photonic hyperthermia-strengthened nanocatalytic therapy of epithelial and embryonal tumors.  CHEMICAL ENGINEERING JOURNAL,  411  (128364).  [PMID:] [10.1016/j.cej.2020.128364]

References

1. Yan-ming Xia, Li-xin Hu, Yun-han Xia, Shi-xuan Li, Bo Shi, Chao Qin, Xiao-peng Han, Su-xin Li, Li-fang Yin.  (2024)  Rational surface modification of zirconium-based metal–organic framework nanomaterials for the adsorption and recovery of coloured drugs and proteins from aqueous solutions.  COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS,  681  (11): (132845).  [PMID:10660610] [10.1016/j.colsurfa.2023.132845]
2. Minghua Zhou, Beibei Tian, Yingcui Bu, Zhichao Wu, Jianhua Yu, Sen Wang, Xianshun Sun, Xiaojiao Zhu, Hongping Zhou.  (2023)  Enhanced pH-Responsive Chemo/Chemodynamic Synergistic Cancer Therapy Based on In Situ Cu2+ Di-Chelation.  ACS Applied Bio Materials,      [PMID:37428493] [10.1021/acsabm.3c00323]
3. Huaming He, Fang Zhao, Wukun Zhong, Yuling Yang, Yuhong Lin, Yihang Ding, Jiajia Yang, Chunhua Lu, Xiankun Tu.  (2022)  GSH-responsive sequential mitochondria-targeting nanoagents for photothermal-enhanced chemodynamic therapy.  MATERIALS & DESIGN,  219  (110722).  [PMID:] [10.1016/j.matdes.2022.110722]
4. Xiangqi Liu, Wei Feng, Huijing Xiang, Baihui Liu, Mujie Ye, Meng Wei, Rui Dong, Yu Chen, Kuiran Dong.  (2021)  Multifunctional cascade nanocatalysts for NIR-II-synergized photonic hyperthermia-strengthened nanocatalytic therapy of epithelial and embryonal tumors.  CHEMICAL ENGINEERING JOURNAL,  411  (128364).  [PMID:] [10.1016/j.cej.2020.128364]

Solution Calculators